EUCTR2018-002470-42-GB进行中(未招募)1 期
Assessment of viral shedding week following administration of live attenuated influenza vaccine in children: FluSHED-2 study - FluSHED-2
Imperial College London JRC Office0 个研究点目标入组 30 人开始时间: 2018年7月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Children age 6 years to 15 years +364 days of age on enrolment
- •2.Children eligible to receive LAIV in accordance with Green Book advice [https://www.gov.uk/government/organisations/public-health-england/series/immunisation-against-infectious-disease-the-green-book]
- •3.Written informed consent given by parent/ guardian and assent from child (both must be in place to proceed).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1.Contraindications to LAIV (notwithstanding allergy to egg protein), which include:
- •a.Hypersensitivity to the active ingredients, gelatin or gentamicin (a possible trace residue)
- •b.Previous systemic allergic reaction to LAIV
- •c.Previous allergic reaction to an influenza vaccine (not LAIV) is a relative contra-indication, which must be discussed with the CI to confirm patient suitability
- •d.Children/adolescents who are clinically immunodeficient due to conditions or immunosuppressive therapy such as: acute and chronic leukaemias; lymphoma; symptomatic HIV infection; cellular immune deficiencies; and high-dose corticosteroids*.
- •*High-dose steroids is defined as a treatment course for at least one month, equivalent to a dose greater than 20mg prednisolone per day (any age), or for children under 20kg, a dose greater than 1mg/kg/day.
- •NB: LAIV is not contraindicated for use in individuals with asymptomatic HIV infection; or individuals who are receiving topical/inhaled/low-dose oral systemic corticosteroids or those receiving corticosteroids as replacement therapy, e.g. for adrenal insufficiency.
- •e.Children / adolescents younger than 18 years of age receiving salicylate therapy because of the association of Reye's syndrome with salicylates and wild-type influenza infection.
- •f.Pregnancy (determined by history). Where this cannot be confirmed, a urine pregnancy test will be performed.
研究者
相似试验
已完成
4 期
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in ChildrenInfluenza VaccinesNCT03735147Imperial College London12
已完成
不适用
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza PatientsInfluenzaNCT01839760Crucell Holland BV150
进行中(未招募)
不适用
Prospective Study of Viral Shedding in Patients with genital HSV-1 and HSV-2 InfectioA60Anogenital herpesviral [herpes simplex] infectionDRKS00012889ationales Centrum für Tumorerkrankungen10
进行中(未招募)
1 期
Assessment of viral shedding in children previously in receipt of multiple doses of live attenuated influenza vaccine (LAIV) compared to influenza vaccine-naïve controls/A - the vaccine will be administered to children according to current DH Immunisation schedule for England.MedDRA version: 20.0 Level: LLT Classification code 10016794 Term: Flu vaccination System Organ Class: 100000004865EUCTR2017-000952-24-GBPublic Health England362
已完成
不适用
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and contactsCOVID-19IgA and IgG antibodies of the recovered COVIDᆧ patientsIgG antibody of the high risk closed contact to COVIDᆧ patients19closed contactantibodyprevalenceTCTR20200708001Center of Excellence in Clinical Virology, Faculty of Medicine Chulalangkorn239
